Home

Aetiology

Alzheimer's Disease

Read time: 2 min

Congress highlights

Markers on the road: not there yet, but making progress

Novel tracers for PET imaging and the increasing range of CSF and plasma assays for amyloid-β and...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Synaptic stimulation protects against pathologic tau

Models of Alzheimer’s disease cast new light on the therapeutic potential of synaptic...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Modulating the microbiome: a revolution in the making?

Altering the intestinal flora can influence host immunity, neuro-inflammation, and the deposition...

Alzheimer's Disease, Parkinson's Disease

Read time: 3 min

Congress highlights

A pick of the mix

Though EAN 2020 was virtual, the variety and quality of its presentations was very real. These are...

Parkinson's Disease

Read time: 2 min

Congress highlights

Who cares for the carers? Everyday insights into Parkinson’s disease

Many people who care for someone with Parkinson’s disease find their role imposes a...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Latest insights into CADASIL and disorders of consciousness

Anti-Notch3 immunotherapy, subclinical command following, and small fibre neuropathy. All topics...

Read time: 3 min

Congress highlights

What causes the different phases of migraine?

Migraine is a complex neurological disorder characterized by a prodromal phase, aura, headache,...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Study motivated by apathy

Conversion from mild cognitive impairment to Alzheimer’s disease dementia is not related to...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Guidance needed on biomarker counseling

Clinicians value biomarkers when assessing mild cognitive impairment but are less certain about how...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Imaging advances diagnosis and staging in dementias

Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and...

Read time: 4 min

Congress highlights

How do cluster headaches differ from migraines?

Cluster headache and other trigeminal autonomic cephalalgias are distinct from migraine and require...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Further evidence of cognitive and health benefits extends lifestyle intervention

The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country